These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 194747)

  • 1. Natural immunity to endogenous oncornaviruses in mice.
    Ihle JN; Hanna MG
    Contemp Top Immunobiol; 1977; 6():169-74. PubMed ID: 194747
    [No Abstract]   [Full Text] [Related]  

  • 2. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens.
    Longstreth JD; Ihle JN; Hanna MG
    Ann N Y Acad Sci; 1976; 276():343-57. PubMed ID: 68698
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity.
    Ihle JN; Lazar B
    J Virol; 1977 Mar; 21(3):974-80. PubMed ID: 191656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprevention of naturally occurring endogenous murine type-C RNA viruses.
    Kende M; Stephenson JR; Kelloff GJ; Al-Ghazzouli IK; Dinowitz M
    Nature; 1978 Jun; 273(5661):383-5. PubMed ID: 207991
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigens induced by the mouse leukemia viruses.
    Pasternak G
    Adv Cancer Res; 1969; 12():1-99. PubMed ID: 4310621
    [No Abstract]   [Full Text] [Related]  

  • 6. AKR-MuLV-associated cell surface antigens.
    Ihle JN; Longstreth JD; Pazmiño NH; McLellan WL; Hanna MG
    Med Microbiol Immunol; 1977; 164(1-3):179-95. PubMed ID: 202850
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses.
    Stephenson JR; Peters RL; Hino S; Donahoe RM; Long LK; Aaronson SA; Kelloff GJ
    J Virol; 1976 Sep; 19(3):890-8. PubMed ID: 184303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses.
    Ihle JN; Domotor JJ; Bengali KM
    J Virol; 1976 Apr; 18(1):124-31. PubMed ID: 176456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group-specific cytolytic antibody directed against the major glycoprotein (gp70) of murine leukemia viruses in serum of mice with dormant FLV infections.
    Callahan RM; Marx PA; Wheelock EF
    Virology; 1979 Aug; 97(1):55-67. PubMed ID: 224581
    [No Abstract]   [Full Text] [Related]  

  • 10. The immune response of (C57BL/6 X C3H)F1 mice to the endogenous AKR-MuLV.
    Ihle JN; Lee JC
    Med Microbiol Immunol; 1977; 164(1-3):207-16. PubMed ID: 202851
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 12. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
    Lee JC; Ihle JN; Huebner R
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):343-7. PubMed ID: 189311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of group- and type-specific antigens in the process of development of viral murine leukemias].
    Gurtsevich VE; Mazurenko NP
    Vopr Onkol; 1973; 19(1):66-70. PubMed ID: 4121908
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 15. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method.
    Steeves RA; Axelrad AA
    Int J Cancer; 1967 May; 2(3):235-44. PubMed ID: 6041991
    [No Abstract]   [Full Text] [Related]  

  • 17. Properties of mouse leukemia viruses. II. Isolation of viral components.
    Schäfer W; Lange J; Fischinger PJ; Frank H; Bolognesi DP; Pister L
    Virology; 1972 Jan; 47(1):210-28. PubMed ID: 4110127
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated.
    Fischinger PJ; Ihle JN; Bolognesi DP; Schäfer W
    Virology; 1976 May; 71(1):346-51. PubMed ID: 179206
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of immunizing properties as well as interferogenicity of some murine leukemia viruses.
    Mazurenko NP; Revazova ES
    Arch Geschwulstforsch; 1970; 35(4):308-14. PubMed ID: 4325787
    [No Abstract]   [Full Text] [Related]  

  • 20. The GIX antigen of murine leukemia virus: an analysis with monoclonal antibodies.
    Pierotti M; DeLeo AB; Pinter A; O'Donnell PV; Hämmerling U; Fleissner E
    Virology; 1981 Jul; 112(2):450-60. PubMed ID: 6167060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.